1 – 10 of 274
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH
(
- Contribution to journal › Article
- 2020
-
Mark
Reduced Apolipoprotein M and Adverse Outcomes across the Spectrum of Human Heart Failure
(
- Contribution to journal › Article
-
Mark
Advances in understanding mechanisms of thrombophilic disorders
(
- Contribution to journal › Scientific review
-
Mark
Genetic risk factors for venous thromboembolism
(
- Contribution to journal › Scientific review
- 2019
-
Mark
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short
(
- Contribution to journal › Article
-
Mark
Plasma Apolipoprotein M and Sphingosine-1-Phosphate Levels are Inversely Associated with Mortality in African Americans with Type 2 Diabetes Mellitus
(
- Contribution to journal › Article
-
Mark
Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
Treating hemophilia by targeting protein S?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
(
- Contribution to journal › Article